Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: Apr 4, 2023
Date Accepted: Aug 30, 2023

The final, peer-reviewed published version of this preprint can be found here:

Psychodermatological Disorders in Patients With Primary Psychiatric Conditions: Cross-Sectional Study

Ajani A, OLANREWAJU FO, Oninla OA, Ibigbami O, Mosaku SK, Onayemi OE, Olasode O

Psychodermatological Disorders in Patients With Primary Psychiatric Conditions: Cross-Sectional Study

JMIR Dermatol 2023;6:e47769

DOI: 10.2196/47769

PMID: 37782534

PMCID: 10580141

Skin diseases and Mental health: A Cross-Sectional Study of Psychodermatological Disorders in Patients with Primary Psychiatric Conditions

  • Atinuke Ajani; 
  • Fatai Olatunde OLANREWAJU; 
  • Olumayowa Abimbola Oninla; 
  • Olanrewaju Ibigbami; 
  • Samuel Kolawole Mosaku; 
  • Olaniyi Emmanuel Onayemi; 
  • Olayinka Olasode

ABSTRACT

Background:

Psychodermatoses and their associations with mental health problems are one of the most frequent research themes in dermatology out-patient settings. Surprisingly however, very few studies have been conducted to evaluate psychodermatoses among subjects with primary psychiatric disorders. As such, the relationship between pre-existing psychiatric disorders and co-morbid psychodermatoses are underrepresented in literature.

Objective:

Aims This study examined the prevalence and distribution spread of psychodermatoses among adults with primary psychiatric disorders and determined the association between psychodermatological disorders and underlying psychiatric diagnosis.

Methods:

A cross-sectional analytical study involving 107 adult psychiatric patients was conducted at a tertiary healthcare facility in Southwestern Nigeria. Co-morbid psychodermatological disorders (PDs) were identified and classified using pre-existing classification systems. Bivariate analysis was conducted to determine the association between psychodermatoses and underlying psychiatric disorders. The level of statistical significance was set at p < 0.05.

Results:

Seventy-five (70.1%) of mental-health patients had at least one co-morbid psychodermatoses. The prevalence of psychodermatoses was highest in patients with affective disorders (75%) and least in those with schizophrenia(68.2%). PDs resulting from delusions/hallucinations (PDDH) and somatoform PPDMS were 9 and 13 times more frequent in patients with anxiety disorders compared with other psychiatric disorders (p= 0.013 and 0.003 respectively) In contrast, patients with schizophrenia were significantly less likely to be diagnosed with PDDH (p=0.002) A weak but significant negative association was also found between psychophysiological PDs and anxiety disorders (phi = -0.236, p=0.015).

Conclusions:

This study provides important insights into the overwhelming burden of psychodermatological conditions in mental health patients and specific associations with underlying psychiatric diagnosis. Clinical Trial: IRC/IEC/00045553


 Citation

Please cite as:

Ajani A, OLANREWAJU FO, Oninla OA, Ibigbami O, Mosaku SK, Onayemi OE, Olasode O

Psychodermatological Disorders in Patients With Primary Psychiatric Conditions: Cross-Sectional Study

JMIR Dermatol 2023;6:e47769

DOI: 10.2196/47769

PMID: 37782534

PMCID: 10580141

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.